Data / Drug companies / CTX Lifesciences Pvt. Ltd.
CTX Lifesciences Pvt. Ltd.: 25 products in the FDA NDC directory, labeler code 42419
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
CTX Lifesciences Pvt. Ltd. (labeler code 42419) lists 25 products in the FDA National Drug Code Directory. By type: 25 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on November 21, 2025.
The request: Watch CTX Lifesciences Pvt. Ltd. (FDA labeler code 42419): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42419
- Products in commercial distribution
- 25
- Packages
- 41
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 1
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- November 4, 2007
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 25 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Linagliptin | 42419-038 | Powder | Bulk ingredients | November 21, 2025 |
| Alogliptin benzoate | 42419-037 | Powder | Bulk ingredients | November 20, 2025 |
| Telmisartan | 42419-035 | Powder | Bulk ingredients | October 24, 2024 |
| Olmesartan medoxomil | 42419-034 | Powder | Bulk ingredients | October 24, 2024 |
| Apixaban | 42419-036 | Powder | Bulk ingredients | October 23, 2024 |
| Chlorthalidone | 42419-032 | Powder | Bulk ingredients | October 23, 2024 |
| Rosuvastatin calcium | 42419-033 | Powder | Bulk ingredients | October 22, 2024 |
| Ticagrelor | 42419-030 | Powder | Bulk ingredients | October 21, 2024 |
| Deferasirox | 42419-031 | Powder | Bulk ingredients | September 4, 2024 |
| Eslicarbazepine acetate | 42419-026 | Powder | Bulk ingredients | January 8, 2016 |
| Mesalamine | 42419-024 | Powder | Bulk ingredients | February 4, 2015 |
| Pregabalin | 42419-019 | Powder | Bulk ingredients | April 23, 2013 |
| Amiodarone hydrochloride | 42419-017 | Powder | Bulk ingredients | April 18, 2013 |
| Carbamazepine | 42419-014 | Powder | Bulk ingredients | April 14, 2012 |
| Carvedilol | 42419-013 | Powder | Bulk ingredients | April 14, 2012 |
| Lamotrigine | 42419-012 | Powder | Bulk ingredients | April 14, 2012 |
| Irbesartan | 42419-011 | Powder | Bulk ingredients | April 13, 2012 |
| Chlorothiazide | 42419-007 | Powder | Bulk ingredients | July 23, 2009 |
| Metoprolol tartrate | 42419-009 | Powder | Bulk ingredients | May 1, 2009 |
| Acetazolamide | 42419-008 | Powder | Bulk ingredients | January 27, 2009 |
| Oxcarbazepine | 42419-006 | Powder | Bulk ingredients | January 27, 2009 |
| Oxymetazoline hydrochloride | 42419-005 | Powder | Bulk ingredients | December 10, 2008 |
| Xylometazoline hydrochloride | 42419-004 | Powder | Bulk ingredients | September 19, 2008 |
| Metoprolol succinate | 42419-003 | Powder | Bulk ingredients | July 19, 2008 |
| Hydrochlorothiazide | 42419-001 | Powder | Bulk ingredients | November 4, 2007 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.